Previous 10 | Next 10 |
At the end of Q3, Glenview Capital Management (Larry Robbins and Mark Horowitz) reported total fund portfolio value of $3.19B in its recent 13F filing.Exits include United Health Group (UNH), Thermo Fisher Scientific (TMO) and Pacific Biosciences of California (PACB).Notable buys include Medt...
Insider buying declined last week with insiders purchasing $102.19 million of stock. Notable Insider Buys: Camping World Holdings, Inc., MultiPlan Corporation, Vertex Pharmaceuticals Incorporated, Aon Plc, American Assets Trust, Inc. Notable Insider Sells: The Carlyle Group Inc., ...
Could These Be The Best Biotech Stocks To Buy Or Sell Right Now? Biotech stocks have been in the center of attention for all the right reasons. It is no surprise after all as biotech companies continue to improve the quality of life that we enjoy today. Human beings are living l...
Pacific Biosciences of California (PACB) has priced underwritten public offering of ~7.4M shares at $14.25/share, for gross proceeds of ~$86.9M.The company is offering ~6.1M common shares and the selling stockholder is offering ~1.3M shares.Offering is expected to close on or about November 1...
Pacific Biosciences of California (PACB) initiates an $85M public offering of common stock. Also, a current investor is offering 1,304,348 common shares. Underwriters' over-allotment is an additional ~196K shares.Price and terms have yet to be announced.Shares down 4% after hours. ...
Pacific Biosciences of California ([[PACB]] -5.1%) Q3 total revenue was $19.1M, compared with $21.9M prior year. Instrument revenue declined $7.7M, from $11.6M prior.Consumables revenue increased to $8M compared with $6.9M.Gross profit of $7.1M vs. $6.9M.Gross margin of 37.0% vs. 31...
Gainers: Inspire Medical Systems (INSP) +24%, GW Pharmaceuticals (GWPH) +15%, Aptevo Therapeutics (APVO) +14%, Galera Therapeutics (GRTX) +11%, DBV Technologies (DBVT) +10%.Losers: Esperion Therapeutics (ESPR) -15%, Aurinia Pharmaceuticals (AUPH)...
Apartment Investment and Management (AIV) -23%.SolarEdge Technologies (SEDG) -18% on Q3 earnings release.Pacific Biosciences of California (PACB) -10% on Q3 earnings release.Aurinia Pharmaceuticals (AUPH) -9% on suspending voclosporin program as Phase 2/3 study f...
Pacific Biosciences of California (NASDAQ: PACB) stock has been on a tear, more than tripling in just the last three months. It definitely helped that a top analyst, J.P. Morgan's Tycho Peterson, raised his price target for PacBio from $5 to $15 early last month. But analyst...
Image source: The Motley Fool. Pacific Biosciences of California (NASDAQ: PACB) Q3 2020 Earnings Call Nov 02, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: Pacific Biosciences of California (PACB) Q3 2020 Earnings...
News, Short Squeeze, Breakout and More Instantly...
Pacific Biosciences of California Inc. Company Name:
PACB Stock Symbol:
NASDAQ Market:
Pacific Biosciences of California Inc. Website:
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
MENLO PARK, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that Novogene is using its Revio long-read sequencing system to expand the capabilities of its new lab in Munich, Germany, se...
A look at the top 10 most actives in the United States Yoshitsu Co. Ltd (TKLF) rose 103.4% to $0.623 on volume of 309,019,720 shares Maxeon Solar Technologies Ltd. (MAXN) rose 11.2% to $0.2524 on volume of 226,231,487 shares NVIDIA Corporation (NVDA) fell 1.6% to $126.36 on volume of 208,...